High risk HLA incompatible kidney transplant in sensitized patients has no survival benefit

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Background

More than 40% of patients awaiting a kidney transplant in the UK are sensitised with human leucocyte antigen (HLA) antibodies. Median time to transplantation for such patients is double that of unsensitised patients at about 74 months. Removing antibody to perform an HL...